Research2Guidance August 31, 2021
How Kenkou’s SDK for apps is revolutionizing heartbeat measurement. Interview with Matthias Puls, CEO of Kenkou.
According to the World Health Organization, cardiovascular diseases (CVDs) are the leading cause of death worldwide. 80% of cardiovascular diseases can be prevented by addressing behaviour risk factors as early as possible. Digital biomarkers can provide vital data measurement that is relevant for preventive personalized cardiovascular care. Together with Matthias Puls, CEO of Kenkou, a Berlin-based health-tech company, we dive into how their software development kit (SDK) offering for apps is revolutionizing heartbeat measurement, the company’s business model and commercial strategy, as well as the future of data-driven precision medicine and the trends that shape this space.
More than 17 million people die each...
Today's Sponsors
Today's Sponsor